Doug leads the global and US advisory teamS at PwC focussed on the pharmaceutical and life sciences industry. Based in Philadelphia, he has over 25 years of experience in the Health Industries.
Doug is responsible for executing the Firm’s industry strategy as well as ensuring that the pharmaceutical and life science practice possesses the skills and capabilities to meet changing client needs. He also works closely with PwC’s Health Services practice to help clients manage the changing healthcare landscape and convergence across the sectors.
Doug is a recognised expert in many areas of the pharmaceutical industry and has served as an Arbitrator several times on complex business and other issues in dispute between organizations. He has served as the Lead Partner on many complex engagements involving Government Programmes including Department of Justice investigations, Compliance Assessments involving Medicaid and Medicare Drug Pricing Programmes, and Sales and Marketing compliance assessments.
Areas of Expertise
Merger and Acquisition strategy and execution, risk and compliance related assessments, and process improvement related projects.